Streetwise Reports' Article Archives — Current Month (8)
FDA Decision on Drug for Bone Marrow Due Early 2025 (12/06/2024)
The manufacturer sheds light on the amount and remittance schedule of the cash payment it must remit to its partner if the drug gets approved, noted a Leede Financial Inc. report.
Drug Trial Shows Positive Interim Results for ALS Treatment (12/06/2024)
Biopharmaceutical company MediciNova Inc. (MNOV:NASDAQ) announced the release of a positive interim analysis of its treatment of Amyotrophic Lateral Sclerosis (ALS). Find out why one analyst says the drug has "potential" to treat the disease and maybe others.
AI Accelerates Breakthroughs in Cancer Drug Discovery (12/03/2024)
Rakovina Therapeutics Inc. (RKV:TSX.V) is advancing cancer drug discovery with its Deep Docking AI platform. Read more about their recent developments and future plans.
Intratubal Insemination Device Shown Effective, Safe (12/03/2024)
Pregnancy rates with this "only new innovation for infertility in decades" were "impressive" in a pivotal study in women with male factor infertility, noted an H.C. Wainwright & Co. report.
Approval Sought in Japan for New Drug to Lower Cholesterol (12/03/2024)
The U.S. biopharma behind the drug is "pushing for accelerated adoption and expansion into additional territories," noted an H.C. Wainwright & Co. report.
Regenerative Medicine Co. Adds Saudi Arabia Diabetes Initiative (12/03/2024)
Leading regenerative medicine company Sernova Corp. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) announces agreement to explore fighting type I diabetes in Saudi Arabia. Read why one analyst believes the company's technology is "advanced."
Is This California Biopharma Co. In the Right Place at the Right Time? (12/03/2024)
Roth MKM analyst Dr. Jonathan Aschoff highlighted GT Biopharma Inc.'s (GTBP:NASDAQ) development of unique precision therapeutic agents using camelid-derived nanobodies.
Developer of Medical Instruments Attracts Research Coverage (12/02/2024)
Both of this Buy-rated company's two business divisions are contributing to topline growth, noted a Leede Financial Inc. report.
More Archives
2024Nov Oct Sep Aug Jul Jun May Apr Mar Feb Jan
2023Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2022Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
